Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FMTX Forma Therapeutics > Detailed Quotes

FMTX Forma Therapeutics

19.9500.0000.00%
Trading Session 10/03 14:35 ET
High
19.980
Open
19.970
Turnover
11.80M
Low
19.940
Pre Close
19.950
Volume
591.71K
Market Cap
954.66M
P/E(TTM)
Loss
52wk High
20.680
Shares
47.85M
P/E(Static)
Loss
52wk Low
4.950
Float Cap
512.88M
Bid/Ask %
85.19%
Historical High
56.330
Shs Float
25.71M
Volume Ratio
0.82
Historical Low
4.950
Dividend TTM
--
Div Yield TTM
--
P/B
2.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.30%
Amplitude
0.20%
Avg Price
19.944
Lot Size
1
Float Cap
512.88M
Bid/Ask %
85.19%
Historical High
56.330
Shs Float
25.71M
Volume Ratio
0.82
Historical Low
4.950
Dividend TTM
--
P/B
2.30
Dividend LFY
--
Turnover Ratio
2.30%
Amplitude
0.20%
Avg Price
19.944
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA.
CEO: Mr. Frank D. Lee
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...